Safety of right liver donation after improving steatosis through weight loss in living donors: a retrospective study

被引:2
作者
Yoon, Young-In [1 ]
Lee, Sung-Gyu [1 ]
Hwang, Shin [1 ]
Kim, Ki-Hun [1 ]
Ahn, Chul-Soo [1 ]
Moon, Deok-Bog [1 ]
Ha, Tae-Yong [1 ]
Song, Gi-Won [1 ]
Jung, Dong-Hwan [1 ]
Park, Gil-Chun [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Surg, Div Hepatobiliary Surg & Liver Transplantat,Coll, 88 Olymp ro 43-gil, Seoul, South Korea
关键词
Fatty liver; Hepatic steatosis; Hepatic steatosis-improved grafts; Living donor; Obese; Right lobe; Transplantation; Weight reduction; HEPATIC STEATOSIS; TRANSPLANTATION;
D O I
10.1007/s12072-024-10641-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Living donor liver transplantation using hepatic steatosis-improved grafts mitigates donor shortage. Herein, we aimed to evaluate the safety and feasibility of right-lobe adult-to-adult living donor liver transplantation using grafts improved through donor weight loss. Methods In this retrospective study conducted in a single institution in the Republic of Korea, we reviewed the medical records of living liver donors who lost >= 10% of their body weight to improve steatosis before right lobe donation between January 2015 and December 2020. Overall, 1040 right-lobe donors were included, with 150 and 890 donors in the weight loss and control (non-steatosis) groups, respectively. Results We performed 1:1 individual matching using the greedy matching method, by which 124 patients were included in each group. The median period from the date of the first visit to donation was 113 (interquartile range: 78-184) days in the weight loss group. As body weight changed from 82.8 +/- 13.7 kg to 70.8 +/- 11.8 kg (p < 0.0001), body mass index also improved from 27.8 +/- 3.9 kg/m(2) to 23.8 +/- 3.1 kg/m(2) (p < 0.0001). No significant between-group differences existed in the postoperative laboratory data for living donors and recipients. The incidence of postoperative complications in donors was comparable between the groups (control group, 9.7%; weight loss group, 13.7%; p = 0.3185). The graft and recipient survival rates were comparable between the groups (p = 1.000). Conclusion Weight loss through diet and exercise significantly could improve hepatic steatosis in living donor candidates for liver transplantation, with the surgical outcomes in recipients and donors being equivalent to those in recipients and non-steatotic donors.
引用
收藏
页码:1566 / 1578
页数:13
相关论文
共 31 条
  • [1] Safe Use of Right Lobe Live Donor Livers With up to 20% Macrovesicular Steatosis Without Compromising Donor Safety and Recipient Outcome
    Bhangui, Prashant
    Sah, Jayant
    Choudhary, Narendra
    Gautam, Dheeraj
    Gupta, Vikas
    Srinivasan, Thiagrajan
    Rastogi, Amit
    Piplani, Tarun
    Saraf, Neeraj
    Saigal, Sanjiv
    Soin, Avi
    [J]. TRANSPLANTATION, 2020, 104 (02) : 308 - 316
  • [2] Effects of Dietary Interventions on Liver Volume in Humans
    Bian, Hua
    Hakkarainen, Antti
    Lundbom, Nina
    Yki-Jarvinen, Hannele
    [J]. OBESITY, 2014, 22 (04) : 989 - 995
  • [3] Living donor liver transplantation
    Broering, DC
    Sterneck, M
    Rogiers, X
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : S119 - S135
  • [4] Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings
    Brunt, Elizabeth M.
    Kleiner, David E.
    Wilson, Laura A.
    Belt, Patricia
    Neuschwander-Tetri, Brent A.
    [J]. HEPATOLOGY, 2011, 53 (03) : 810 - 820
  • [5] Expanding Indications for Liver Transplant: Tumor and Patient Factors
    Chu, Kevin Ka-Wan
    Wong, Kelly Hiu-Ching
    Chok, Kenneth Siu-Ho
    [J]. GUT AND LIVER, 2021, 15 (01) : 19 - 30
  • [6] Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review
    Chu, Michael J. J.
    Dare, Anna J.
    Phillips, Anthony R. J.
    Bartlett, Adam S. J. R.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (09) : 1713 - 1724
  • [7] Efficacy and Safety of Weight Reduction of the Donor in Hepatic Steatosis for Living Donor Liver Transplantation
    Chung, Jae Hun
    Ryu, Je Ho
    Yang, Kwang Ho
    Choi, Byung Hyun
    Park, Youngmok
    Lee, Tae Beom
    Shim, Jae Ryong
    Ko, Hyo Jung
    Cho, Sung Hwan
    [J]. ANNALS OF TRANSPLANTATION, 2020, 25 : 1 - 7
  • [8] Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed Algorithm
    Danis, Nilay
    Weeks, Sharon R.
    Kim, Ahyoung
    Baghdadi, Azarakhsh
    Ghadimi, Maryam
    Kamel, Ihab R.
    Saberi, Behnam
    Woreta, Tinsay
    Garonzik-Wang, Jacqueline
    Philosophe, Benjamin
    Gurakar, Ahmet
    Loomba, Rohit
    [J]. LIVER TRANSPLANTATION, 2022, 28 (04) : 670 - 677
  • [9] Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation
    Doyle, Adam
    Adeyi, Oyedele
    Khalili, Korosh
    Fischer, Sandra
    Dib, Martin
    Goldaracena, Nicolas
    Dillon, Jayne
    Grant, David
    Cattral, Mark
    McGilvray, Ian
    Greig, Paul
    Ghanekar, Anand
    Lilly, Leslie
    Renner, Eberhard
    Levy, Gary
    Selzner, Nazia
    [J]. LIVER TRANSPLANTATION, 2016, 22 (09) : 1295 - 1300
  • [10] Short- and Long-term Outcomes After Steatotic Liver Transplantation
    Doyle, M. B. Majella
    Vachharajani, Neeta
    Wellen, Jason R.
    Anderson, Christopher D.
    Lowell, Jeffrey A.
    Shenoy, Surendra
    Brunt, Elizabeth M.
    Chapman, William C.
    [J]. ARCHIVES OF SURGERY, 2010, 145 (07) : 653 - 660